iPROLEPSIS

📌 @iprolepsis Key Facts Series: Intimacy, Reproductive Health and Family Life Living with psoriatic arthritis may affect relationships, sexual and reproductive health, and family planning decisions. Learn more: iprolepsis.eu/learning-hub-n… #PsoriaticArthritis #PsA #HorizonEurope

At the European OHDSI Symposium 2026 in Rotterdam, AINIGMA presented @iprolepsis through a poster on cross-country harmonisation of #PsoriaticArthritis cohorts into the OMOP Common Data Model. #PsoriaticArthritis #OHDSI #OMOP #RealWorldData

In March, @PLUXBiosignals showcased @iprolepsis at BIOSTEC 2026 in Marbella and Healthcare & Medical Equipment Korea 2026 in Seoul, helping raise the project’s visibility and support networking around biosignals, digital health and medtech. #PsoriaticArthritis #DigitalHealth

@iprolepsis was presented at the TeraMed Conference 2026 in Angola by Filipa Magalhães from FMH/IST ULisboa, highlighting the project and the iPROLEPSIS Games as examples of gamified digital health innovation. iprolepsis.eu/news/iprolepsi… #psoriaticarthritis #DigitalHealth

📌 @iprolepsis Key Facts Series: Living with psoriatic arthritis Living with PsA can affect work, sleep, fatigue and mental wellbeing. Everyday tips: balancing work, improving sleep, managing fatigue and supporting mental wellbeing. 🔗 iprolepsis.eu/learning-hub-n… #PsoriaticArthritis

🗞️ The 11th @iprolepsis Newsletter is out! Featuring a new video with @iprolepsis, @aiprognosis & @REBECCA_project, new publications, and a major milestone: PDPID recruitment completed (>490 participants). Read more: iprolepsis.eu/_files/ugd/981… #psoriaticarthritis #digitalhealth

New joint video from @iprolepsis, @aiprognosis & @REBECCA_project. Highlighting how AI & digital biomarkers support earlier prediction, monitoring & personalised care in Parkinson’s disease, psoriatic arthritis & breast cancer. 🎥 youtube.com/watch?v=hWu3bP… #HorizonEurope

📚 New @iprolepsis publication: “Modeling Interphalangeal Joints for Swelling Assessment in #PsoriaticArthritis via Smartphone Photographs”, a logistic regression model detecting joint swelling from smartphone photos, validated in 85 patients. 🔗 zenodo.org/records/184815…

📚 New @iprolepsis publication: “Designing Exergames for Psoriatic Arthritis: The Spy and Zen Forest Paradigms” (HealthCom2025) Co-designed exergames supporting physical activity in #PsoriaticArthritis through therapeutic gameplay. 🔗 zenodo.org/records/184689…

New publication from @iprolepsis in JMIR Serious Games: Co-Designing Mobile Serious Games to Support Patients With Psoriatic Arthritis and Chronic Pain: Mixed Methods Study. 🔗 games.jmir.org/2026/1/e75072 #SeriousGames #DigitalHealth #PsoriaticArthritis

Understanding treatment options and lifestyle support helps people with PsA take an active role in their care. Learn more on the @iprolepsis Learning Hub 👉 iprolepsis.eu/learning-hub-n… #PsA #PsoriaticArthritis #DigitalHealth #iPROLEPSIS

✨ We wish you a warm and peaceful holiday season. May the coming year bring good health, positive moments, and new opportunities. Happy holidays! @iprolepsis

✔️ Day 2 of the 7th @iprolepsis Plenary Meeting wrapped up with clear priorities for the next phase. We discussed progress on the IDBV, PPIDC, MOJMI & PDPID studies and worked on next steps for upcoming deployments. Thank you to @SPReumatologia for organising! #PsoriaticArthritis

💡 Day 1 of the 7th @iprolepsis Plenary Meeting is underway! Organised by @SPReumatologia and hosted at @nova_medschool, Lisbon. We reviewed project progress and discussed key updates in digital phenotyping and data harmonisation. On to Day 2! #PsoriaticArthritis #HorizonEurope

📚 On 20 November, @iprolepsis was presented at FMH during the PhD seminar “Métodos de Investigação Avançada em Motricidade Humana.” Sofia Balula Dias gave a lecture to PhD students about the key results from our latest publications and research on #psoriaticarthritis.

🌍 The @iprolepsis consortium is gearing up for its 7th Plenary Meeting on 9-10 Dec 2025 in Lisbon. Partners will meet to review progress, discuss updates on data, studies and digital tools, and plan the next steps. Looking forward to productive discussions.

@iprolepsis at SPIN RISE – REWIRE Georgios Apostolidis (AUTH) joined the final SPIN RISE – REWIRE event in Lisbon (11–13 Nov), pitching a digital biomarker for immune status in PsA developed in @iprolepsis and joining a networking session with Web Summit participants. #28DGTL

📌 The @iprolepsis Games were showcased at Lisboa Games Week 2025 by the team from FMH/IST-ULisboa. Great demos, inspiring talks, and direct exchanges with industry! 🔗 lisboagamesweek.pt #SeriousGames #DigitalHealth #HorizonEurope

What is psoriatic arthritis? It’s an inflammatory arthritis linked with psoriasis, causing joint pain, swelling and stiffness. Most people are diagnosed between 30–50. Learn more on the @iprolepsis Learning Hub: iprolepsis.eu/learning-hub-n… #PsA #PsoriaticArthritis #Psoriasis

The latest @iprolepsis newsletter is out. Discover highlights from World Psoriasis Day, the HaDEA feature article, our renewed Learning Hub, and international events advancing digital PsA care. iprolepsis.eu/_files/ugd/981… #psoriaticarthritis #healthtech #AI